癌症中的METTL16:作用和调控机制
Kangjie Qiu1, Shuxin Zhong1, Jinyi Liu2
1Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China.
Genes & diseases
|December 29, 2025
概括
调节RNA甲基化 (m6A) 的酶METTL16在癌症中至关重要. 了解其在癌症进展和耐药性方面的作用,可能会导致针对这一关键表观遗传调节器的新疗法策略.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症研究 癌症研究
背景情况:
- 基因表达调节在癌症中至关重要.
- RNA甲基化,特别是N6-甲基氨酸 (m6A),是一种重要的表观遗传修饰.
- METTL16是一种关键酶,负责m6A甲基化.
研究的目的:
- 审查METTL16在癌症中的功能和调控机制.
- 阐明METTL16.6的A-依赖和A-独立的角色.
- 探索METTL16作为潜在的癌症治疗点.
主要方法:
- 关于METTL16在癌症中的作用的文献综述.
- 分析METTL16对RNA代谢和稳定性的影响.
- 检查METTL16与癌症特征的关联.
主要成果:
- METTL16失调与癌症的扩散,入侵,转移和耐药性有关.
- METTL16通过m6的A-依赖和独立途径影响RNA的稳定性和功能.
- 癌症中METTL16的特定机制尚未完全理解,但至关重要.
结论:
- METTL16在癌症的发展和进展中起着重要作用.
- 准METTL16为新型癌症疗法提供了一个有前途的战略.
- 对METTL16机制的进一步研究对于治疗开发是有必要的.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K


